Evidence map›Paper›PMID 31085610›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Sabitha Joseph, Siv Vingill, Olaf Jahn, Robert Fledrich, Hauke B Werner, Istvan Katona, Wiebke Möbius, Mišo Mitkovski, Yuhao Huang, Joachim Weis and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. SKP1-CUL1-F-box: Key molecular targets affecting disease progression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A Conserved Requirement forFrontiers in physiology · 2019
    Article
  12. ASN neuro
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Sabitha JosephDepartment of Neurology, RWTH University Hospital, 52074 Aachen, Germany.
Siv VingillOxford Parkinson's Disease Centre, University of Oxford, Oxford OX1 3QX, United Kingdom.
Olaf JahnProteomics Group, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.ORCID 0000-0002-3397-8924
Robert FledrichInstitute of Anatomy, Department of Neuropathology, University Hospital Leipzig, 04103 Leipzig, Germany.
Hauke B WernerDepartment of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.ORCID 0000-0002-7710-5738
Istvan KatonaDepartment of Neuropathology, RWTH University Hospital, 52074 Aachen, Germany.ORCID 0000-0002-0955-8911
Wiebke MöbiusElectron Microscopy Facility, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.ORCID 0000-0002-2902-7165
Mišo MitkovskiLight Microscopy Facility, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.
Yuhao HuangDepartment of Neurology, RWTH University Hospital, 52074 Aachen, Germany.
Joachim WeisDepartment of Neuropathology, RWTH University Hospital, 52074 Aachen, Germany.
Michael W SeredaMolecular and Translational Neurology, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.
Jörg B SchulzDepartment of Neurology, RWTH University Hospital, 52074 Aachen, Germany.ORCID 0000-0002-8903-0593
Klaus-Armin NaveDepartment of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany.ORCID 0000-0001-8724-9666
Judith StegmüllerDepartment of Neurology, RWTH University Hospital, 52074 Aachen, Germany, jstegmueller@ukaachen.de.ORCID 0000-0003-4172-7778
Max Planck Institute of Experimental Medicine · DERWTH Aachen University · DEForschungszentrum Jülich · DEUniversity Hospital Leipzig · DEUniversity of Oxford · GB

Funding

Parkinson's UK J-0901
6 · The paper itself

Abstract

Myelination of axons facilitates the rapid propagation of electrical signals and the long-term integrity of axons. The ubiquitin-proteasome system is essential for proper protein homeostasis, which is particularly crucial for interactions of postmitotic cells. In our study, we examined how the E3 ubiquitin ligase FBXO7-SCF (SKP1, Cul1, F-box protein) expressed in myelinating cells affects the axon-myelin unit. Deletion of

Indexed as

AnimalsApoptosisAxonsCells, CulturedCentral Nervous SystemF-Box ProteinsFemaleGene DeletionMaleMiceMice, Inbred C57BLMyelin SheathPeripheral Nervous System DiseasesProteasome Endopeptidase ComplexF-Box ProteinsFBXO7 protein, mouseProteasome Endopeptidase Complexaxonal degenerationFBXO7myelinneuropathyproteasome

Identifiers

PMID31085610
PMCPMC6616290
OpenAlexW2945811894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.